[1]Kröger K., Ose C., Rudofsky G., Roesener J., Hirche H. Symptoms in individuals with small cutaneous veins. Vasc Med. 2002;7:13-17.
[2]Ruckley C.V., Evans C.J., Allan P.L., Lee A.J., Fowkes F.G.R. Telangiectasia in the Edinburgh vein study: epidemiology and association with trunk varices and symptoms. Eur J Vasc Endovasc Surg. 2008;36:719-724.
[3]Langer R.D., Ho E., Denenberg J., Fronek A., Allison M., Criqui M. Relationships between symptoms and venous disease. The San Diego population study. Arch Intern Med. 2005;165:1420-1424.
[4]Eklöf B., Rutherford R.B., Bergan J.J. American venous forum International Ad-Hoc Committee for revision of the CEAP classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248-1252.
[5]Schul M.W., Eaton T., Erdman B. Compression sclerotherapy for patients with isolated refluxing reticular veins and telangiectasia: a randomized trial comparing quality-of-life outcomes. Phlebology. 2011;26:148-156. versus 4
[6]Carpentier P.H., Poulain C., Fabry R., Chleir F., Guias B., Bettarel-Binon C. Ascribing leg symptoms to chronic venous disorders: the construction of a diagnostic score. J Vasc Surg. 2007;46:991-996.
[7]Ramelet A.A., Monti M. Phlebology. The guide. Paris: Elsevier; 1999.
[8]Rabe E., Pannier-Fischer F., Bromen K. Bonner Venenstudie der Deutschen Gesellschaft für Phlebologie. Phlebologie. 2003;32:1-14.
[9]Rabe E. Bonn vein study. Phlebologie. 2006;59:179-186. 2
[10]Partsch H., Flour M., Coleridge Smith P. Indications for compression therapy in venous and lymphatic disease. Consensus based on experimental data and scientific evidence. Int Angiol. 2008;27:193-219. 1
[11]Vayssairat M., Ziani E., Houot B. Placebo controlled efficacy of class 1 elastic stockings in chronic venous insufficiency of the lower limbs. J Mal Vasc. 2000;25:256-262. 4
[12]Benigni J.P., Sadoun S., Allaert F.A., Vin F. Efficacy of class 1 elastic compression stockings in the early stages of chronic venous disease. A comparative study. Int Angiol. 2003;22:383-392. 4
[13]Amsler F., Blättler W. Compression therapy for occupational leg symptoms and chronic venous disorders – a meta-analysis of randomised controlled trials. Eur J Vasc Endovasc Surg. 2008;35:366-372.
[14]Blättler W., Thomae H.J., Amsler F. Venous leg symptoms in healthy subjects assessed during prolonged standing. J Vasc Surg Venous Lymphat Disord. 2016;4:455-462. 4
[15]Benigni J.P., Uhl J.F., Balet F., Chahim M. Treatment protocol on stasis edema in poorly mobile nursing home patients. Int Angiol. 2018;37:396-399. 5
[16]Danzinger N. Pathophysiology of pain in venous diseas. Phlebolymphology. 2008;15:107-114. 3
[17]Uhl J.F., Chahim M., Allaert F.A. Static foot disorders: a major risk factor for chronic venous disease? Phlebology. 2012;27:13-18. 1
[18]Saggini R., Bellomo R.G., Iodice P., Lessiani G. Venous insufficiency and foot dysmorphism: effectiveness of visco-elastic rehabilitation systems on veno-muscle system of the foot and of the calf. Int J Immunopathol Pharmacol. 2009;22:1-8. 3 Suppl
[19]Benigni J.P., Cady J. Effectiveness of weight loss on the evolution of chronic venous insufficiency (CVI) after bariatric surgery in obese patients. Obesity Surgery A. 2008;18:442-444. 4
[20]Frederick N., Brand A.L., Dannenberg R.D. The epidemiology of varicose veins: the Framingham study. Am J Prev Med. 1988;4:96-101. 2
[21]Ramelet A.A., Boisseau M.R., Allegra C. Veno-active drugs in the management of chronic venous disease. An international consensus statement: current medical position, prospective views and final resolution. Clin Hemorheol Microcirc. 2005;33:309-319.
[22]Schul M.W., Eaton T., Erdman B. Compression sclerotherapy for patients with isolated refluxing reticular veins and telangiectasia: a randomized trial comparing quality-of-life outcomes. Phlebology. 2011;26:148-156. versus4